8-azidoadenosine-3',5'-monophosphate has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 2 studies
Studies (8-azidoadenosine-3',5'-monophosphate) | Trials (8-azidoadenosine-3',5'-monophosphate) | Recent Studies (post-2010) (8-azidoadenosine-3',5'-monophosphate) | Studies (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Trials (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) | Recent Studies (post-2010) (4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone) |
---|---|---|---|---|---|
119 | 1 | 1 | 449 | 1 | 24 |
Protein | Taxonomy | 8-azidoadenosine-3',5'-monophosphate (IC50) | 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (IC50) |
---|---|---|---|
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 4.55 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Rattus norvegicus (Norway rat) | 6 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 4.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 4.8 | |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 4.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kammer, GM; Mitchell, E | 1 |
Averill, LE; Kammer, GM; Stein, RL | 1 |
2 other study(ies) available for 8-azidoadenosine-3',5'-monophosphate and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Article | Year |
---|---|
Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adult; Antigens, Surface; Azides; Colforsin; Cyclic AMP; Female; Humans; Immunologic Capping; Lupus Erythematosus, Systemic; Male; Receptors, Cyclic AMP; T-Lymphocytes | 1988 |
Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenylyl Cyclases; Adolescent; Adult; Aged; Azides; Calcimycin; Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Immunologic; Female; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Phosphorylation; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1988 |